Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression-Reference-Cited by-同舟云学术

Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression

Published:2019-12 Issue: Volume:18 Page:388-399
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Liao Keman,Lin Yingying,Gao Weizhen,Xiao Zhipeng,Medina Rogelio,Dmitriev Pauline,Cui Jing,Zhuang Zhengping,Zhao Xiaochun,Qiu Yongming,Zhang Xiaohua,Ge Jianwei,Guo Liemei

Funder

National Natural Science Fund

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference39 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N. Engl. J. Med.,2005

2. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment;Ganipineni;J. Control. Release,2018

3. Current state of immunotherapy for glioblastoma;Lim;Nat. Rev. Clin. Oncol.,2018

4. Stereotactic Radiosurgery and Hypofractionated Radiotherapy for Glioblastoma;Shah;Neurosurgery,2018

5. Zinc fingers and homeoboxes family in human diseases;Liu;Cancer Gene Ther.,2015

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glioblastoma stem cell long non-coding RNAs: therapeutic perspectives and opportunities;Frontiers in Genetics;2024-07-02

2. Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance;Non-coding RNA Research;2024-06

3. Long non-coding RNA MALAT1 in hematological malignancies and its clinical applications;Chinese Medical Journal;2024-04-01

4. Engineered smart materials for RNA based molecular therapy to treat Glioblastoma;Bioactive Materials;2024-03

5. Expression of lncRNAs in glioma: A lighthouse for patients with glioma;Heliyon;2024-02